These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10617300)

  • 1. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype.
    Garcia JM; Silva JM; Dominguez G; Gonzalez R; Navarro A; Carretero L; Provencio M; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Oct; 57(3):237-43. PubMed ID: 10617300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
    Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Altered expression of PTEN gene and LOH of its epigenetic microsatellite in gastric carcinoma].
    Li JY; Zheng HC; Yang L; Xu L; Yang XF; Gao H; Zhang YC; Xin Y
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):389-92. PubMed ID: 15355640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas.
    Leighton X; Srikantan V; Pollard HB; Sukumar S; Srivastava M
    Cancer Lett; 2004 Jul; 210(2):239-44. PubMed ID: 15183540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
    Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
    Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas.
    Bose S; Wang SI; Terry MB; Hibshoosh H; Parsons R
    Oncogene; 1998 Jul; 17(1):123-7. PubMed ID: 9671321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer.
    Rubin MA; Gerstein A; Reid K; Bostwick DG; Cheng L; Parsons R; Papadopoulos N
    Hum Pathol; 2000 Apr; 31(4):504-8. PubMed ID: 10821499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
    Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y
    Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of breast carcinomas with allelic loss in the p73 region.
    Dominguez G; Silva J; Silva JM; Garcia JM; Miralles C; Rodriguez O; Jareño E; Provencio M; España P; Bonilla F
    Breast Cancer Res Treat; 2000 Sep; 63(1):17-22. PubMed ID: 11079155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral heterogeneity in microsatellite alterations in BRCA1 and PTEN regions in sporadic colorectal cancer.
    Garcia JM; Rodriguez R; Silva J; Muñoz C; Dominguez G; Silva JM; Carcereny E; Provencio M; España P; Bonilla F
    Ann Surg Oncol; 2003 Oct; 10(8):876-81. PubMed ID: 14527905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
    Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
    Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.
    Kulke MH; Odze RD; Thakore KS; Thomas G; Wang H; Loda M; Eng C
    Br J Cancer; 2001 Mar; 84(6):748-53. PubMed ID: 11259087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
    Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
    Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.